# Renal-Type Clear Cell Carcinoma of the Prostate: A Histopathological Case Report of a Rare and Underrecognized Variant

**Authors:** George Stoyanov, Dobri Marchev, Pavel Pavlov, Hristo Popov

PMC · DOI: 10.3390/reports9010063 · Reports - Clinical Practice and Surgical Cases · 2026-02-14

## TL;DR

This case report describes a rare type of prostate cancer that resembles kidney cancer and highlights the need for careful diagnosis.

## Contribution

The paper presents a rare histopathological variant of prostate cancer not recognized by the WHO.

## Key findings

- A 73-year-old male was diagnosed with renal-type clear cell carcinoma of the prostate after biopsy and imaging.
- The tumor's morphology resembled renal cell carcinoma, requiring careful differential diagnosis.
- Immunohistochemistry confirmed the diagnosis after ruling out concurrent kidney cancer.

## Abstract

Background and Clinical Significance: Prostatic malignancies are amongst the leading malignancies in incidence. They represent a mixed group of conditions, predominantly characterized by adenocarcinomas, which are themselves predominantly acinar. Case Presentation: Herein, we present a morphological case report of a 73-year-old male who underwent transrectal ultrasound-guided needle biopsy due to elevated PSA levels (18.61 ng/mL). Histopathology of the biopsy specimen was represented by pleomorphic cells with predominantly clear cytoplasm, with relatively eccentric, pyknotically appearing nuclei with hyperchromatic chromatin and no visible nucleoli. After imaging excluded concomitant renal malignancy and confirmatory immunohistochemistry was carried out, the patient was diagnosed with renal-type clear cell carcinoma of the prostate. Conclusions: While unrecognized by the WHO due to its rarity, renal-type clear cell acinar adenocarcinoma of the prostate is a unique type of prostatic malignancy, which, due to its morphological appearance, necessitated careful differential diagnosis.

## Linked entities

- **Diseases:** prostate cancer (MONDO:0005159), renal cell carcinoma (MONDO:0005086)

## Full-text entities

- **Genes:** NKX3-1 (NK3 homeobox 1) [NCBI Gene 4824] {aka BAPX2, NKX3, NKX3.1, NKX3A}, MME (membrane metalloendopeptidase) [NCBI Gene 4311] {aka CALLA, CD10, CMT2T, NEP, SCA43, SFE}, PAX8 (paired box 8) [NCBI Gene 7849] {aka PAX-8}, NPEPPS (aminopeptidase puromycin sensitive) [NCBI Gene 9520] {aka AAP-S, MP100, PSA}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, AMACR (alpha-methylacyl-CoA racemase) [NCBI Gene 23600] {aka AMACRD, CBAS4, P504S, RACE, RM}, KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}
- **Diseases:** hepatocellular carcinomas (MESH:D006528), solid (MESH:D018250), Prostatic malignancies (MESH:D011472), RCC (MESH:D002292), kidney (MESH:D007674), Acinar adenocarcinomas (MESH:D018267), ductal carcinomas (MESH:D044584), Clear (MESH:D018227), cerebrovascular (MESH:D002561), metastases (MESH:D009362), hypertension (MESH:D006973), malignancies (MESH:D009369), Ductal adenocarcinomas (MESH:D000230), liver, colorectal, gastric, pancreatic and esophageal malignancies (MESH:D010195), urinary and male genital tumors (MESH:D005834), gastric and pancreatic carcinomas (MESH:C562463), injury to (MESH:D014947), venous outflow obstruction of (MESH:D006502)
- **Chemicals:** H&amp;E (MESH:D006371), androgen blockade (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922115/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12922115/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922115/full.md

---
Source: https://tomesphere.com/paper/PMC12922115